Vanqua Bio
Home Page
United States · Founded 2019 · $136.0M raised
- Employees
- 11–50
- Founded
- 2019
- Business Model
- B2B
- Website
- vanquabio.com
- Total Funding
- $136.0M
- Last Round
- $45.0M Series BSep 2021
- Rounds
- 3
About
Biopharmaceutical company focused on discovering next-generation medicines for neurodegenerative diseases.
Summary
Vanqua Bio is a Biotech company based in United States, founded in 2019. It has raised $136.0M in total across 3 rounds, most recently a $45.0M Series B round in Sep 2021. Investors include OrbiMed, Omega Funds and Surveyor Capital.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Sep 2021
Sign up to see all 3 rounds
Series B — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/vanqua-bio"><img src="https://indexed.vc/api/badge/company/vanqua-bio" alt="Vanqua Bio on Indexed.vc" width="260" height="76" /></a>